Page last updated: 2024-10-27

fusaric acid and Laryngeal Neoplasms

fusaric acid has been researched along with Laryngeal Neoplasms in 1 studies

Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research Excerpts

ExcerptRelevanceReference
"Head and neck squamous cell carcinoma (HNSCC) can become resistant to some chemotherapy and becomes a clinical challenge when it recurs."1.39Effects of fusaric acid treatment on HEp2 and docetaxel-resistant HEp2 laryngeal squamous cell carcinoma. ( Montero, M; Stack, BC; Ye, J, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ye, J1
Montero, M1
Stack, BC1

Other Studies

1 other study available for fusaric acid and Laryngeal Neoplasms

ArticleYear
Effects of fusaric acid treatment on HEp2 and docetaxel-resistant HEp2 laryngeal squamous cell carcinoma.
    Chemotherapy, 2013, Volume: 59, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 7; Caspase 9; Cell Line, Tumor;

2013